Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE: Serine and Fenofibrate in Macular Telangiectasia Type 2
NCT04907084Phase 2Completed
- Sponsor
- Lowy Medical Research Institute
- Start
- Apr 2022
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fenofibrate, serine in macular telangiectasia type 2 (MacTel), sponsored by Lowy Medical Research Institute. Started Apr 2022; status: completed.
02
Drugs
fenofibrateserine
03
Conditions
macular telangiectasia type 2 (MacTel)
Beyond the preview
Go deeper on NCT04907084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04907084.